Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers

Betanin is a bioactive compound with a high antioxidant activity and therapeutic potential. However, incomplete oral absorption and low stability of betanin limit its application. To surmount these limitations, betanin was encapsulated with nanoliposomes, nanoparticles exhibiting suitable physicoche...

Full description

Bibliographic Details
Main Authors: Sajed Amjadi, Mehran Mesgari Abbasi, Behrooz Shokouhi, Marjan Ghorbani, Hamed Hamishehkar
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464619302713
_version_ 1828962567154827264
author Sajed Amjadi
Mehran Mesgari Abbasi
Behrooz Shokouhi
Marjan Ghorbani
Hamed Hamishehkar
author_facet Sajed Amjadi
Mehran Mesgari Abbasi
Behrooz Shokouhi
Marjan Ghorbani
Hamed Hamishehkar
author_sort Sajed Amjadi
collection DOAJ
description Betanin is a bioactive compound with a high antioxidant activity and therapeutic potential. However, incomplete oral absorption and low stability of betanin limit its application. To surmount these limitations, betanin was encapsulated with nanoliposomes, nanoparticles exhibiting suitable physicochemical properties. Additionally, betanin-loaded nanoliposomes revealed a relatively good sustained release profile in the simulated gastric and intestinal fluids. In vitro digestion stability of betanin and its antioxidant activity were significantly improved by liposomal encapsulation. These nanocarriers were assessed in vivo for their therapeutic potency in streptozotocin induced rats. The results showed that the administration of betanin-loaded nanoliposomes was significantly more effective than free betanin in positively regulate hyperglycemia, hyperlipidemia and oxidative stress. Moreover, the histopathological analysis showed that the tissue damage in kidney, liver and pancreas was reduced in the betanin-loaded nanoliposomes treated diabetic rats. In conclusion nanoliposomes are suitable nanocarriers for improving the stability and therapeutic potential of betanin.
first_indexed 2024-12-14T10:07:49Z
format Article
id doaj.art-e4ea7ee1b18f4458b22fae72bcd7252d
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-14T10:07:49Z
publishDate 2019-08-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-e4ea7ee1b18f4458b22fae72bcd7252d2022-12-21T23:07:06ZengElsevierJournal of Functional Foods1756-46462019-08-0159119128Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriersSajed Amjadi0Mehran Mesgari Abbasi1Behrooz Shokouhi2Marjan Ghorbani3Hamed Hamishehkar4Department of Food Science and Technology, Faculty of Agriculture, Urmia University, Urmia, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IranDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Pathology, Tabriz University of Medical Sciences, Tabriz, IranStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, IranDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Corresponding author at: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Betanin is a bioactive compound with a high antioxidant activity and therapeutic potential. However, incomplete oral absorption and low stability of betanin limit its application. To surmount these limitations, betanin was encapsulated with nanoliposomes, nanoparticles exhibiting suitable physicochemical properties. Additionally, betanin-loaded nanoliposomes revealed a relatively good sustained release profile in the simulated gastric and intestinal fluids. In vitro digestion stability of betanin and its antioxidant activity were significantly improved by liposomal encapsulation. These nanocarriers were assessed in vivo for their therapeutic potency in streptozotocin induced rats. The results showed that the administration of betanin-loaded nanoliposomes was significantly more effective than free betanin in positively regulate hyperglycemia, hyperlipidemia and oxidative stress. Moreover, the histopathological analysis showed that the tissue damage in kidney, liver and pancreas was reduced in the betanin-loaded nanoliposomes treated diabetic rats. In conclusion nanoliposomes are suitable nanocarriers for improving the stability and therapeutic potential of betanin.http://www.sciencedirect.com/science/article/pii/S1756464619302713BetaninNanoliposomesSustained releaseDigestion stabilityDiabetes
spellingShingle Sajed Amjadi
Mehran Mesgari Abbasi
Behrooz Shokouhi
Marjan Ghorbani
Hamed Hamishehkar
Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
Journal of Functional Foods
Betanin
Nanoliposomes
Sustained release
Digestion stability
Diabetes
title Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
title_full Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
title_fullStr Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
title_full_unstemmed Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
title_short Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
title_sort enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers
topic Betanin
Nanoliposomes
Sustained release
Digestion stability
Diabetes
url http://www.sciencedirect.com/science/article/pii/S1756464619302713
work_keys_str_mv AT sajedamjadi enhancementoftherapeuticefficacyofbetaninfordiabetestreatmentbyliposomalnanocarriers
AT mehranmesgariabbasi enhancementoftherapeuticefficacyofbetaninfordiabetestreatmentbyliposomalnanocarriers
AT behroozshokouhi enhancementoftherapeuticefficacyofbetaninfordiabetestreatmentbyliposomalnanocarriers
AT marjanghorbani enhancementoftherapeuticefficacyofbetaninfordiabetestreatmentbyliposomalnanocarriers
AT hamedhamishehkar enhancementoftherapeuticefficacyofbetaninfordiabetestreatmentbyliposomalnanocarriers